Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2025-12-25 @ 4:19 AM
NCT ID:
NCT04762420
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 18-75 years;
* Above patients who underwent general anesthesia with rocuronium neuromuscular blockade and subsequent reversal with sugammadex.
Exclusion Criteria:
* American Society of Anesthesiologists physical status V;
* Emergency surgery;
* Hypersensitivity history to rocuronium or sugammadex;
* Severe renal impairment/dialysis;
* Neuromuscular diseases;
* Severe hepatic disease;
* Pre-existing coagulopathies;
* Pregnancy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04762420
Study Brief:
Protocol Section:
NCT04762420